Kyntra Bio(NASDAQ:KYNB) reported that its rebranding, asset sale, and debt payoff have shifted the company’s financial structure and enabled a clinical focus on oncology and rare disease. Management ...
Kyntra Bio, Inc. (NASDAQ:KYNB) Q4 2025 Earnings Call Transcript March 16, 2026 Kyntra Bio, Inc. beats earnings expectations. Reported EPS is $-3.61, expectations were $-3.885. Operator: Thank you for ...
Tired of being spoon-fed the algorithm and want to bypass the chaos of social feeds? Kadaza homepage puts you back in the ...
Eli Lilly (LLY) rated Sell/Avoid: overvaluation, slowing GLP-1 growth, Novo competition, bearish technicals and insider ...
BofA Securities 2026 Information & Business Services Conference March 12, 2026 2:15 PM EDTCompany ParticipantsAdam ...
Pure is a hookup app for anonymous casual encounters. It's designed to get you laid quickly and discreetly, with no strings ...